26.04.2024 15:02:59 - dpa-AFX: *AMGEN TO SUBMIT MAA TO EMA FOR TEPROTUMUMAB IN THYROID EYE DISEASE TREATMENT

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
AMGEN INC. DL-,0001 867900 Xetra 288,950 13.05.24 09:18:15 -1,900 -0,65% 286,950 288,450 288,900 290,850

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH